subject: Aarkstore Enterprise Disease And Therapy Review: Overactive Bladder [print this page] The Overactive Bladder Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide. Information on diagnosis is provided, with discussion of tests used during examination and diagnosis. Treatment options, including behavioral, medical and surgical options, are discussed. Dosing and treatment costs for commonly used pharmacoligical agents are provided, along with market size estimates and market share and sales of leading therapies. General comments are also included.
Additional Information
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Table of Contents :
I. OVERVIEW
II. INCIDENCE AND PREVALENCE
Prevalence Table: (US, UK, France, Germany, Italy, Spain, Japan, Worldwide)
